Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 3391-3404

  Wang, Huimin ^a   Tan, Mingzi ^a   Zhang, Song ^a   Li, Xiao ^a   Gao, Jian ^a   Zhang, Danye ^a   Hao, Yingying ^a   Gao, Song ^a   Liu, Juanjuan ^a   Lin, Bei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

C met; CD44; CD47; Immunohistochemistry; Ovarian clear cell carcinoma

Indexed keywords

CARBOPLATIN; CD47 ANTIGEN; HERMES ANTIGEN; PACLITAXEL; PLATINUM; SCATTER FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE CLASSIFICATION; DRUG RESISTANCE; FEMALE; FOLLOW UP; GASTROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UPREGULATION; ADENOCARCINOMA, CLEAR CELL; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PATHOLOGY; PROGNOSIS;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTIGENS, CD44; ANTIGENS, CD47; BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 84922364212     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16023391     Document Type: Article

References (29)

1. Ho, C.M.; Wang, Y.J.; Hen, T.C.; Huang, S.H.; Liu, F.S.; Chang Chien, C.C.; Yu, M.H.; Mao, T.L.; Wang, T.Y.; Hsieh, C.Y. Pure-type clear cell carcinoma of the obary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol. Oncol. 2004, 94, 197–203.
2. Del Carmen, M.G.; Birrer, M.; Schorge, J.O. Clear cell carcinoma of the ovary: A review of the literature. Gynecol. Oncol. 2012, 126, 481–490.
3. Fujisaki, T.; Tanaka, Y.; Fujii, K.; Mine, S.; Saito, K.; Yamada, S.; Yamashita, U.; Irimura, T.; Eto, S. CD44 stimulation induces integrin mediated adhesion of colon cancer cell lines to endothelial cells by up regulation of integrins and c-Met and activation of integrins. Cancer Res. 1999, 59, 4427–4434.
4. Rousseau, V.; Morrison, H.; Matzke, A. Hepatocyte growth factor induced Ras activation requires ERM proteins linked to both CD44V6 and F-Actin. Mol. Biol. Cell. 2007, 18, 76–83.
5. Baccelli, I.; Schneeweiss, A.; Stenzinger, A.; Schillert, A.; Vogel, V.; Klein, C.; Saini, M.; Bäuerle, T.; Wallwiener, M.; et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 2013, 31, 539–545.
6. Rodríguez-Rodríguez, L.; Sancho-Torres, I.; Leakey, P.; Gibbon, D.G.; Comerci, J.T.; Ludlow, J.W.; Mesonero, C. CD44 splice variant expression in clear cell carcinoma of the ovary. Gynecol. Oncol. 1998, 71, 223–229.
7. Sancho-Torres, I.; Mesonero, C.; Miller Watelet, J.L.; Gibbon, D.; Rodríguez-Rodríguez, L. Clear cell carcinoma of the ovary: Characterization of its CD44 isoform repertoire. Gynecol. Oncol. 2000, 79, 187–195.
8. Yamamoto, S.; Tsuda, H.; Miyai, K.; Takano M, Tamai S, Matsubara O. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: Their roles in tumor progression and prognostication of the patient. Mod. Pathol. 2011, 24, 1146–1155.
9. Baohui, J.; Yuting, H.; Jing, T.; Hui F.; Linping H.; Weiping Y.; Quan H. In vitro application of anti-CD47 monoclonal antibody for targeted therapy of ovarian cancer. Chin. J. Clin. Oncol. 2013, 40, 440–443.
10. Manabu, Y.; Yoshiya, T.; Koichi, F.; Yasumoto, K. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int. Immunol. 2001, 13, 1309–1319.
11. Marhaba, R.; Bourouba, M.; Zoller, M. CD44v6 promotes proliferation by persisting activation of MAP kinases. Cell Signal. 2005, 17, 961–973.
12. En Kajita, M.; Itoh, Y.; Chiba, T.; Okada, A.; Kinoh, H.; Seiki, M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. Cell Biol. 2001, 153, 893–904.
13. Sawada, K.; Radjabi, A.R.; Shinomiya, N.; Kistner, E.; Kenny, H.; Becker, A.R.; Turkyilmaz, M.A.; Salgia, R.; Yamada, S.D.; van de Woude G.F; et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res. 2007, 67, 1670–1679.
14. Matsumura, A.; Kubota, T.; Taiyoh, H.; Fujiwara, H.; Okamoto, K.; Ichikawa, D.; Shiozaki, A.; Komatsu, S.; Nakanishi, M.; Kuriu, Y.; et al. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Int. J. Oncol. 2013, 42, 535–542.
15. Damm, S.; Koefinger, P.; Stefan, M.; Wels, C.; Mehes, G.; Richtig, E.; Kerl, H.; Otte, M.; Schaider, H. HGF Promotes Motility in Primary Human Melanocytes through CD44v6 via a NF-κB/Egr-1/C/EBP-β complex. J. Investig. Dermatol. 2010, 130, 1893–1903.
16. Chuan, Y.C.; Iglesias-Gato, D.; Fernandez-Perez, L.; Cedazo-Minguez, A.; Pang, S.T.; Norstedt, G.; Pousette, A.; Flores-Morales, A. Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene 2010, 29, 1531–1542.
17. Fehon, R.G.; McClatchey, A.I.; Bretscher, A. Organizing the cell cortex: The role of ERM proteins. Nat. Rev. Mol. Cell. Biol. 2010, 11, 276–287.
18. Jun, Sh.; Zhou, Zh.; Wen D.; Li, N. Correlation of CD44v6 expression with ovarian cancer progression and recurrence. BMC Cancer 2013, 8, doi:10.1186/1471-2407-13-182.
19. Zhang, J.; Chang, B.; Liu, J. CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis. Hum. Pathol. 2013, 44, 1882–1891.
20. Matozaki, T.; Murata, Y.; Okazaw, H.; Ohnishi, H. Functions and molecular mechanisms of the CD47-SIRPα signalling pathway. Trends Cell. Biol. 2009, 19, 72–80.
21. Kim, M.J.; Lee, J.C.; Lee, J.J.; Kim, S.; Lee, S.G.; Park, S.W.; Sung, M.W.; Heo, D.S. Association of CD47 with natural killer cell-mediated cytotoxicity of head- and neck squamous cell carcinoma lines. Tumour Biol. 2008, 29, 28–34.
22. Willingham, S.B.; Volkmer, J.P.; Gentles, A.J.; Sahoo, D; Dalerba, P.; Mitra, S.S.; Wang, J.; Contreras-Trujillo, H.; Martin, R.; Cohen, J.D.; et al. The CD47-signal regulatory protein alpha (SIRPα) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. USA 2012, 109, 6662–6667.
23. Jaiswal, S.; Chao, M.P.; Majeti, R.; Weissman, I.L. Macrophages as mediators of tumor immunosurveillance. Trends Immunol. 2010, 31, 212–219.
24. Camerlingo, R.; Ferraro, G.A.; de Francesco, F.; Romano, M.; Nicoletti, G.; di Bonito, M.; Rinaldo, M.; D’Andrea, F.; Pirozzi, G. The role of CD44+/CD24−/low biomarker for screening, diagnosis and monitoring of breast cancer. Oncol. Rep. 2014, 31, 1127–1132.
25. Takaishi, S.; Okaumura, T.; Tu, S.; Wang, S.S.W.; Shibata, W.; Vigneshwaran, R.; Gordon, S.A.K.; Shimada, Y.; Wang, T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27, 1006–1020.
26. Chan, K.S.; Espinosa, I.; Chao, M.; Wong, D.; Ailles, L.; Diehn, M.; Gill, H.; Presti, J.; Chang, H.Y.; van de Rijn, M.; et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. USA 2009, 106, 14016–14021.
27. Chan, K.S.; Volkmer, J.P.; Weissman, I. Cancer stem cells in bladder cancer: A revisited and evolving concept. Curr. Opin. Urol. 2010, 20, 393–397.
28. Scarpino, S.; Di Napoli, A.; Taraboletti, G.; Cancrini, A.; Ruco, L.P. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells. J. Pathol. 2005, 205, 50–56.
29. Shinohara, M.; Ohyama, N.; Murata, Y.; Okazawa, H.; Ohnishi, H.; Ishikawa, O.; Matozaki, T. CD47 regulation of epithelial cell spreading and migration, and its signal transduction. Cancer Sci. 2006, 97, 889–895.